CST3 and type 2 diabetes mellitus: A recent study showed that cystatin C (CysC) was independently associated with PAD in type 2 diabetes mellitus patients without overt nephropathy, while 24 h-urine albumin and serum creatine were not independent risk factors for PAD [11].